Anna M. Stagner

Anna M. Stagner

Auto-generated profile, based on publicly available information

Anna M. Stagner

David G. Cogan Laboratory of Ophthalmic Pathology, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, U.S.A.

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
PDF file
MHMelissa D. Halpern
Melissa D. Halpern
JCJessica A. Clark
Jessica A. Clark
TSTara A. Saunders
Tara A. Saunders
SDSarah M. Doelle
Sarah M. Doelle
DHDania Molla Hosseini
Dania Molla Hosseini
BDBohuslav Dvorak
Bohuslav Dvorak
Necrotizing enterocolitis (NEC) is the most common gastrointestinal disease of premature infants. However, despite significant morbidity and mortality, the etiology and pathogenesis of NEC are poorly understood. Evidence suggests that ileal proinflammatory mediators such as IL-18 contribute to the pathology associated with this disease. In addition, we have previously shown that upregulation of TNF-α in the liver is correlated with ileal disease severity in a neonatal rat model of NEC. With the use of a neonatal rat model of NEC, we evaluated the incidence and severity of ileal damage along with the production of both hepatic and ileal proinflammatory cytokines in animals injected with (anti-TNF-α; n = 23) or without (NEC; n = 25) a monoclonal anti-TNF-α antibody. In addition, we assessed changes in apoptosis and ileal permeability in the NEC and anti-TNF-α groups. Ileal damage was significantly decreased, and the incidence of NEC was reduced from 80% to 17% in animals receiving anti-TNF-α. Hepatic TNF-α and hepatic and ileal IL-18 were significantly decreased in pups given anti-TNF-α compared with those sham injected. In addition, ileal luminal levels of both TNF-α and IL-18 were significantly decreased in the anti-TNF-α-injected group. Ileal paracellular permeability and the proapoptotic markers Bax and cleaved caspase-3 were significantly decreased in the anti-TNF-α group. These data show that hepatic TNF-α is an important component for the development of NEC in the neonatal rat model and suggest that anti-TNF-α could be used as a potential therapy for human NEC.

1 January 2017 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
CZChengxin Zhou
Chengxin Zhou
MRMarie-Claude Robert
Marie-Claude Robert
VKVassiliki Kapoulea
Vassiliki Kapoulea
FLFengyang Lei
Fengyang Lei
ASAnna M. Stagner
Anna M. Stagner
EPEleftherios I. Paschalis
Eleftherios I. Paschalis
Purpose: Tumor necrosis factor (TNF)-α is upregulated in eyes following corneal alkali injury and contributes to corneal and also retinal damage. Prompt TNF-α inhibition by systemic infliximab ameliorates retinal damage and improves corneal wound healing. However, systemic administration of TNF-α inhibitors carries risk of significant complications, whereas topical eye-drop delivery is hindered by poor ocular bioavailability and the need for patient adherence. This study investigates the efficacy of subconjunctival delivery of TNF-α antibodies using a polymer-based drug delivery system (DDS). Methods: The drug delivery system was prepared using porous polydimethylsiloxane/polyvinyl alcohol composite fabrication and loaded with 85 μg of infliximab. Six Dutch-belted pigmented rabbits received ocular alkali burn with NaOH. Immediately after the burn, subconjunctival implantation of anti-TNF-α DDS was performed in three rabbits while another three received sham DDS (without antibody). Rabbits were followed with photography for 3 months. Results: After 3 months, the device was found to be well tolerated by the host and the eyes exhibited less corneal damage as compared to eyes implanted with a sham DDS without drug. The low dose treatment suppressed CD45 and TNF-α expression in the burned cornea and inhibited retinal ganglion cell apoptosis and optic nerve degeneration, as compared to the sham DDS treated eyes. Immunolocalization revealed drug penetration in the conjunctiva, cornea, iris, and choroid, with residual infliximab in the DDS 3 months after implantation. Conclusions: This reduced-risk biologic DDS improves corneal wound healing and provides retinal neuroprotection, and may be applicable not only to alkali burns but also to other inflammatory surgical procedures such as penetrating keratoplasty and keratoprosthesis implantation.

16 July 2015 in Neuropathology
Verified
Journal Article
Closed access
PDF file
Andrey KorshunovAndrey Korshunov
Andrey Korshunov
FJFrederick A. Jakobiec
Frederick A. Jakobiec
CECharles G. Eberhart
Charles G. Eberhart
VHVolker Hovestadt
Volker Hovestadt
DCDavid Capper
David Capper
MKMarcel Kool
Marcel Kool

1 May 2016 in Survey of Ophthalmology
Verified
Journal Article
Closed access
FJFrederick A. Jakobiec
Frederick A. Jakobiec
ATAristomenis Thanos
Aristomenis Thanos
ASAnna M. Stagner
Anna M. Stagner
HGHans E. Grossniklaus
Hans E. Grossniklaus
APAlan D. Proia
Alan D. Proia

1 January 2014 in Cornea
Verified
Journal Article
Closed access
DGDevin Gattey
Devin Gattey
AZAngela Y. Bsc Zhu
Angela Y. Bsc Zhu
ASAnna Stagner
Anna Stagner
MTMark A. Terry
Mark A. Terry
AJAlbert S. Jun
Albert S. Jun
Purpose: The aim was to report 4 cases of Fuchs endothelial corneal dystrophy (FECD) in patients with an established diagnosis of myotonic dystrophy (DM) and suggest a mechanism for their association based on the known molecular genetics and potential pathophysiological parallels of DM and FECD. Methods: We reviewed all available medical records and pathology slides for the 4 reported cases from the Department of Ophthalmology at Oregon Health and Science University's Casey Eye Institute and Devers Eye Institute at the Legacy Good Samaritan Medical Center in Portland, OR. Results: Four patients were found to have DM and bilateral corneal guttae, consistent with the diagnosis of FECD. All the identified patients were female and were aged between 34 and 63, and 2 patients were related (mother and daughter). The corneal specimens from 2 of the 4 patients who had undergone a corneal transplant were pathologically confirmed to be consistent with the diagnosis of FECD. Conclusions: To our knowledge, FECD has not been previously reported in association with DM. Because both diseases are somewhat prevalent in the United States, it is possible that their coexistence is merely a coincidence in these patients. However, recent studies into the pathogenesis of each disease have shown more parallels between FECD and DM, suggesting the possibility of a noncoincidental association. Potential mutual pathogenic mechanisms may involve altered protein expression causing the deregulation of ion homeostasis, an unstable intronic trinucleotide repeat expansion, or activation of the unfolded protein response and oxidative stress pathways.

1 June 2015 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
FJFrederick A. Jakobiec
Frederick A. Jakobiec
MKMarcel Kool
Marcel Kool
ASAnna M. Stagner
Anna M. Stagner
Stefan PfisterStefan Pfister
Stefan Pfister
RERalph C. Eagle
Ralph C. Eagle
Andrey KorshunovAndrey Korshunov
Andrey Korshunov